Down-regulation of integrin αMβ2 ligand-binding function by the urokinase-type plasminogen activator receptor

Biochemical and Biophysical Research Communications

Volumn 348, Issue 3, 2006, Pages 1184-1193

  Tang, Man Li ^a   Kong, Le Sheng ^b   Law, S K Alex ^a   Tan, Suet Mien ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cell adhesion; Integrins; Urokinase type plasminogen activator receptor

Indexed keywords

FIBRINOGEN; INTEGRIN; INTEGRIN ALPHAMBETA2; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANTIBODIES, MONOCLONAL; CELL LINE; CELL MOVEMENT; DOWN-REGULATION; HUMANS; LIGANDS; MACROPHAGE-1 ANTIGEN; PROTEIN BINDING; RECEPTORS, CELL SURFACE; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 33747174596     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.179     Document Type: Article

References (62)

1. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
2. Ehlers M.R. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes. Infect. 2 (2000) 289-294
3. Simon D.I., Ezratty A.M., Francis S.A., Rennke H., and Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1: a nonplasmin fibrinolytic pathway. Blood 82 (1993) 2414-2422
4. Wright S.D., Rao P.E., Van Voorhis W.C., Craigmyle L.S., Iida K., Talle M.A., Westberg E.F., Goldstein G., and Silverstein S.C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80 (1983) 5699-5703
5. Diamond M.S., Staunton D.E., de Fougerolles A.R., Stacker S.A., Garcia-Aguilar J., Hibbs M.L., and Springer T.A. ICAM-1: a counter-receptor for Mac-1. J. Cell Biol. 111 (1990) 3129-3139
6. Altieri D.C., Morrissey J.H., and Edgington T.S. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc. Natl. Acad. Sci. USA 85 (1988) 7462-7466
7. Sheng N., Fairbanks M.B., Heinrikson R.L., Canziani G., Chaiken I.M., Mosser D.M., Zhang H., and Colman R.W. Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 and blocks adhesion to fibrinogen and ICAM-1. Blood 95 (2000) 3788-3795
8. Moyle M., Foster D.L., McGrath D.E., Brown S.M., Laroche Y., De Meutter J., Stanssens P., Bogowitz C.A., Fried V.A., and Ely J.A. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J. Biol. Chem. 269 (1994) 10008-10015
9. Davis G.E. The Mac-1 and p150,95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp. Cell Res. 200 (1992) 242-252
10. Sitrin R.G., Todd R.F., Albrecht E., and Gyetko M.R. The urokinase receptor facilitates CD11b/CD18-mediated adhesion of human monocytes. J. Clin. Invest. 97 (1996) 1942-1951
11. Zhang H., Colman R.W., and Sheng N. Regulation of CD11b/CD18 adhesion to fibrinogen by urokinase receptor. Inflamm. Res. 52 (2003) 86-93
12. Simon D.I., Wei Y., Zhang L., Rao N.K., Xu H., Chen Z., Liu Q., Rosenberg S., and Chapman H.A. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275 (2000) 10228-10234
13. Chapman H.A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9 (1997) 714-724
14. Preissner K.T., Kanse S.M., and May A.E. Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12 (2000) 621-628
15. Tarui T., Mazar A.P., Cines D.B., and Takada Y. Urokinase-type plasminogen activator receptor is a ligand for integrins and mediates cell-cell interaction. J. Biol. Chem. 276 (2001) 3983-3990
16. Xue W., Kindzelskii A.L., Todd R.F., and Petty H.R. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J. Immunol. 152 (1994) 4630-4640
17. Xue W., Mizukami I., Todd R.F., and Petty H.R. Urokinase-type plasminogen activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57 (1997) 1682-1689
18. Wei Y., Eble J.A., Wang Z., Kreidberg J.A., and Chapman H.A. Urokinase receptors promote β1 integrin function through interactions with integrin α3β1. Mol. Biol. Cell 12 (2001) 2975-2986
19. Tarui T., Andronicos N., Czekay R.P., Mazar A.P., Bdeir K., Parry G.C., Kuo A., Loskutoff D.J., Cines D.B., and Takada Y. Critical role of integrin α5β1 in urokinase/urokinase receptor signaling. J. Biol.Chem. 278 (2003) 29863-29872
20. 2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood 101 (2003) 1582-1590
21. Bohuslav J., Horejsi V., Hansmann C., Stockl J., Weidle U.H., Majdic O., Bartke I., Knapp W., and Stockinger H. Urokinase plasminogen activator receptor, β2- integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181 (1995) 1381-1390
22. Kindzelskii A.L., Laska Z.O., Todd R.F., and Petty H.R. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 during neutrophil polarization. J. Immunol. 156 (1996) 297-309
23. Wei Y., Czekay R.P., Robillard L., Kugler M.C., Zhang F., Kim K.K., Xiong J.P., Humphries M.J., and Chapman H.A. Regulation of α5β1 integrin conformation and function by urokinase receptor binding. J. Cell Biol. 168 (2005) 501-511
24. 2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J. Biol. Chem. 279 (2004) 18063-18072
25. Plow E.F., Herren T., Redlitz A., Miles L.A., and Hoover-Plow J.L. The cell biology of the plasminogen system. FASEB J. 9 (1995) 939-945
26. Hildreth J.E., Gotch F.M., Hildreth P.D., and McMichael A.J. A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur. J. Immunol. 13 (1983) 202-208
27. Hildreth J.E., and August J.T. The human lymphocyte function-associated antigen and a related macrophage differentiation antigen: functional effects of subunit-specific monoclonal antibodies. J. Immunol. 134 (1985) 3272-3280
28. Poloni F., Puddu P., Moretti F., Flego M., Romagnoli G., Tombesi M., Capone I., Chersi A., Felici F., and Cianfriglia M. Identification of a LFA-1 region involved in the HIV-1-induced syncytia formation through phage-display technology. Eur. J. Immunol. 31 (2001) 57-63
29. Uciechowski P., and von Schmidt R.E. Leukocyte Typing IV White Cell Differentiation Antigens (1989), Oxford University Press, UK
30. Diamond M.S., Garcia-Aguilar J., Bickford J.K., Corbi A.L., and Springer T.A. The I domain is a major recognition site on the leukocyte integrin Mac-1 for four distinct adhesion ligands. J. Cell Biol. 120 (1993) 1031-1043
31. Robinson M.K., Andrew D., Rosen H., Brown D., Ortlepp S., Stephens P., and Butcher E.C. Antibody against the Leu-CAM β-chain promotes both LFA-1- and CR3-dependent adhesion events. J. Immunol. 148 (1992) 1080-1085
32. Tan S.M., Robinson M.K., Drbal K., van Kooyk Y., Shaw J.M., and Law S.K. The N-terminal region and the mid-region complex of the integrin β2 subunit. J. Biol. Chem. 276 (2001) 36370-36376
33. Tng E., Tan S.M., Ranganathan S., Cheng M., and Law S.K. The integrin αLβ2 hybrid domain serves as a link for the propagation of activation signal from its stalk regions to the I-like domain. J. Biol. Chem. 279 (2004) 54334-54339
34. Li Y., Lawrence D.A., and Zhang L. Sequences within domain II of the urokinase receptor critical for differential ligand recognition. J. Biol. Chem. 278 (2003) 29925-29932
35. Tan S.M., Hyland R.H., Al-Shamkhani A., Douglass W.A., Shaw J.M., and Law S.K. Effect of integrin β2 subunit truncations on LFA-1 and Mac-1 assembly, surface expression, and function. J. Immunol. 165 (2000) 2574-2581
36. Cai T.Q., and Wright S.D. Energetics of leukocyte integrin activation. J. Biol. Chem. 270 (1995) 14358-14365
37. Barclay A.N., Brown M.H., Law S.K., McKnight A.J., Tomlinson M.G., and van der Merwe P.A. The Leucocyte Antigen Facts Book. second ed. (1997), Academic Press, London, UK
38. Hyland R.H., Douglass W.A., Tan S.M., and Law S.K. Chimeras of the integrin β subunit mid-region reveal regions required for heterodimer formation and for activation. Cell Commun. Adhes. 8 (2001) 61-69
39. Simon D.I., Rao N.K., Xu H., Wei Y., Majdic O., Ronne E., Kobzik L., and Chapman H.A. Mac-1 and the urokinase receptor form a functional unit on monocytic cells. Blood 88 (1996) 3185-3194
40. DuBridge R.B., Tang P., Hsia H.C., Leong P.M., Miller J.H., and Calos M.P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell Biol. 7 (1987) 379-387
41. Heinzel S.S., Krysan P.J., Calos M.P., and DuBridge R.B. Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J. Virol. 62 (1988) 3738-3746
42. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., and Arnaout M.A. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science 296 (2002) 151-155
43. Lee J.O., Bankston L.A., Arnaout M.A., and Liddington R.C. Two conformations of the integrin A-domain (I-domain): a pathway for activation?. Structure 3 (1995) 1333-1340
44. Shi M., Sundramurthy K., Liu B., Tan S.M., Law S.K., and Lescar J. The crystal structure of the plexin-semaphorin-integrin domain/hybrid domain/I-EGF1 segment from the human integrin β2 subunit at 1.8-A resolution. J. Biol. Chem. 280 (2005) 30586-30593
45. Beglova N., Blacklow S.C., Takagi J., and Springer T.A. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat. Struct. Biol. 9 (2002) 282-287
46. Violette S.M., Rusche J.R., Purdy S.R., Boyd J.G., Cos J., and Silver S. Differences in the binding of blocking anti-CD11b monoclonal antibodies to the A-domain of CD11b. J. Immunol. 155 (1995) 3092-3101
47. Lu C., Oxvig C., and Springer T.A. The structure of the β-propeller domain and C-terminal region of the integrin αM subunit. Dependence on β subunit association and prediction of domains. J. Biol. Chem. 273 (1998) 15138-15147
48. Lu C., Ferzly M., Takagi J., and Springer T.A. Epitope mapping of antibodies to the C-terminal region of the integrin β2 subunit reveals regions that become exposed upon receptor activation. J. Immunol. 166 (2001) 5629-5637
49. Yang W., Shimaoka M., Salas A., Takagi J., and Springer T.A. Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc. Natl. Acad. Sci. USA 101 (2004) 2906-2911
50. Degryse B., Resnati M., Czekay R.P., Loskutoff D.J., and Blasi F. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J. Biol. Chem. 280 (2005) 24792-24803
51. Arnaout M.A., Mahalingam B., and Xiong J.P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21 (2005) 381-410
52. Llinas P., Le Du M.H., Gardsvoll H., Dano K., Ploug M., Gilquin B., Stura E.A., and Menez A. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J. 24 (2005) 1655-1663
53. Elemer G.S., and Edgington T.S. Microfilament reorganization is associated with functional activation of αMβ2 on monocytic cells. J. Biol. Chem. 269 (1994) 3159-3166
54. Altieri D.C. Occupancy of CD11b/CD18 divalent ion binding site(s) induces leukocyte adhesion. J. Immunol. 147 (1991) 1891-1898
55. Petty H.R., and Todd R.F. Integrins as promiscuous signal transduction devices. Immunol. Today 17 (1996) 209-212
56. Gyetko M.R., Aizenberg D., and Mayo-Bond L. Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J. Leukoc. Biol. 76 (2004) 648-656
57. Gyetko M.R., Sud S., Kendall T., Fuller J.A., Newstead M.W., and Standiford T.J. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165 (2000) 1513-1519
58. Dewerchin M., Nuffelen A.V., Wallays G., Bouche A., Moons L., Carmeliet P., Mulligan R.C., and Collen D. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest. 97 (1996) 870-878
59. Cao C., Lawrence D.A., Li Y., Von Arnim C.A., Herz J., Su E.J., Makarova A., Hyman B.T., Strickland D.K., and Zhang L. EMBO J. 25 (2006) 1860-1870
60. Kjoller L. The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility. Biol. Chem. 383 (2002) 5-19
61. Trigwell S., Wood L., and Jones P. Soluble urokinase receptor promotes cell adhesion and requires tyrosine-92 for activation of p56/59(hck). Biochem. Biophys. Res. Commun. 278 (2000) 440-446
62. Arias-Salgado E.G., Lizano S., Sarkar S., Brugge J.S., Ginsberg M.H., and Shattil S.J. Src kinase activation by direct interaction with the integrin β cytoplasmic domain. Proc. Natl. Acad. Sci. USA 100 (2003) 13298-13302